The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

cyberheartinc.com

Executives

4

Board of Directors

2

Cyberheart Board of Directors

2 Board of directors

Cyberheart has 2 board of directors, including Allan May.

Name

Firm

Work History

Other Seats

Allan May

Allan May Chairman Allan was Managing Partner of Emergent Medical Partners Venture Fund, and has been founder, Chairman, CEO, or investor in over 80 medtech, biotech, and diagnostic startups. He was a co-founder and Chairman of Nanostim, developer of a Leadless Cardiac pacemaker, which was acquired by St. Jude Medical in 2013, and co-founder and Chairman of Hyalex Surgical, Inc, developer of a novel artificial cartilage for total joint replacements. He currently serves on the boards of Noctrix Health, Celero Systems, and Zeto, Inc. In 2018, Allan co-founded Woodside Medical, an incubator helping commercialize U.S. medical technologies in China. In 2020, Allan joined the Medtech Convergence Fund as a Venture Partner. MCF is focused on the shift from intervention to prevention, invasive to non-invasive and hospitals to the home, improving patient access while lowering the costs of managing disease.

Cyberheart

Thomas Fogarty

Cyberheart

Name

Allan May

Thomas Fogarty

Firm

Work History

Allan May Chairman Allan was Managing Partner of Emergent Medical Partners Venture Fund, and has been founder, Chairman, CEO, or investor in over 80 medtech, biotech, and diagnostic startups. He was a co-founder and Chairman of Nanostim, developer of a Leadless Cardiac pacemaker, which was acquired by St. Jude Medical in 2013, and co-founder and Chairman of Hyalex Surgical, Inc, developer of a novel artificial cartilage for total joint replacements. He currently serves on the boards of Noctrix Health, Celero Systems, and Zeto, Inc. In 2018, Allan co-founded Woodside Medical, an incubator helping commercialize U.S. medical technologies in China. In 2020, Allan joined the Medtech Convergence Fund as a Venture Partner. MCF is focused on the shift from intervention to prevention, invasive to non-invasive and hospitals to the home, improving patient access while lowering the costs of managing disease.

Other Seats

Cyberheart

Cyberheart

Cyberheart Management Team

4 Team Members

Cyberheart has 4 executives. Cyberheart's current Chief Executive Officer, President is Patrick J Maguire.

Name

Work History

Title

Status

Patrick J Maguire

Chief Executive Officer, President

Current

William G Mavity

Chief Executive Officer

Former

Thilaka Sumanaweera

Chief Technology Officer

Former

Darrin Uecker

Executive Vice President

Former

Name

Patrick J Maguire

William G Mavity

Thilaka Sumanaweera

Darrin Uecker

Work History

Title

Chief Executive Officer, President

Chief Executive Officer

Chief Technology Officer

Executive Vice President

Status

Current

Former

Former

Former

You May Also Like

N
Neurosonix

NeuroSonix is an Israeli medical device company targeting the market of cerebral embolic protection during cardiac surgical and other minimally invasive procedures. NeuroSonix has conceived, developed and patented a technology and medical devices for the prevention of acute cerebral embolism during open-heart cardiac surgery as well as other invasive and minimally-invasive procedures. The company's technology, which is based on ultrasound, aims to enable a non-invasive deflection of embolic material flowing inside the body, away from the cerebral arteries. This new ultrasonic modality aims to reduce the embolic load on the patient's brain. The first product developed by the company is the EmBlocker"ž, intended to provide protection from acute cerebral embolism during cardiac surgical procedures. The Protection Collar, the company's second product, is intended for embolic protection during minimally-invasive procedures and Cath-lab practice.

O
OrSense

OrSense provides non-invasive monitoring of various blood constituencies.

I
InnerPulse

InnerPulse develops minimally invasive devices for cardiac rhythm management

A
Axis Surgical Technologies

Axis Surgical Technologies, Inc. aims to develop, manufacture, and market devices that improve quality and efficiency in spinal surgery, especially for minimally invasive surgical techniques. Based in Mountain View, California, Axis offers an integration of visualization and articulation capabilities and provides spinal surgery equipment.Axis' FDA Grant In March 2010, Axis announced that it received 510(k) clearance from the Food and Drug Administration to market its C-MOR„ Visualization Device to use in diagnostic and operative arthroscopic and endoscopic procedures. This portable tool provides visualization and illumination of an interior cavity through either a natural or surgical opening. The ergonomic lightweight device also offers practitioners the convenience of endoscopic visualization and efficient one-handed operating ability; this device can be employed in hospital outpatient departments, ambulatory surgery centers, and office surgery suites.

A
Advanced Surgical Concepts

Advanced Surgical Concepts develops surgical instruments for use in endoscopy and in minimally invasive surgery

A
Arbor Surgical Technologies

Arbor Surgical Technologies, Inc. with facilities located in Irvine and Portola Valley, CA (USA), is a privately held cardiovascular medical device company focused on the heart valve replacement market. Founded in 2002 by Dr. Thomas J. Fogarty and noted heart valve designer, Ernie Lane, Arbor is developing multiple technologies that have the potential to deliver significant clinical benefit to patients worldwide. Arbor intends to develop and commercialize its core technologies in varying combinations, giving the company the opportunity to create a broad portfolio of product offerings. Currently in clinical trials, Arbor is developing a tissue heart valve family of products designed for improved performance over existing valves and compatible implantation tools that simplify and speed valve replacement surgery. Arbor Surgical Technologies mission is to simplify cardiac valve surgery through the innovative development of a less invasive, unique implantation system and valves with superior performance and durability. Partnering with physicians, we will improve patient recovery by less invasive techniques and reduced surgery time. Ethical behavior with employees, surgeons, patients and suppliers is the keystone to our success.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.